Robb Gary Charles bought CORT
December 24, 2025 · Form 4 insider transaction
Robb Gary Charles bought 145,000 shares of Corcept Therapeutics Incorporated at $3.88 per share, a transaction worth $562.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.